LS ARK Genomic Revolution Tracker ETP Securities (ARKC) 1.7115 GBP (+0.03%) | Healthcare London Stock Exchange

Listed investment company focused on companies involved in the genomic revolution, including biotechnology and health technologies.

Comment

Performance & Momentum

6 Months –

1 Year –

3 Years –

5 Years 4,272 %

Momentum

Unlock this indicator

Strategic Analysis

LS ARK Genomic Revolution Tracker ETP Securities provides targeted exposure to leading companies at the forefront of the genomic revolution and advanced biotechnology worldwide. Its approach is based on an innovative thematic selection focused on personalized healthcare and disruptive life sciences technologies.

Strengths

Unique positioning in a sector undergoing rapid digitalization and genomic transformation
Global diversification across innovative companies with strong growth potential
Very strong long-term historical performance, reflecting the maturity and attractiveness of the theme

Weaknesses

High exposure to a volatile and technically complex segment of the healthcare sector
The lack of recent intermediate performance data may limit short-term visibility

Momentum

Current strong momentum highlights sustained investor interest, reinforced by a steady pace of innovation in biotechnology. This favorable trend suggests considering this ETP as a high-performing vehicle for exposure to the global medical transformation theme.

Analysis performed 2 months ago